Blog
Latest articles, insights, and updates from the blog.
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.
Esketamine's Role in Treatment-Resistant Depression
A new clinical overview examines esketamine's place in TRD care, including patient selection, access barriers, and rapid-acting benefits for suicidal ideation.
Glutamate Pathway Treatments Reshape TRD Care in 2026
A 2026 review in Psychiatric Times highlights how esketamine and glutamate-targeting drugs are changing treatment-resistant depression care.
TRD Management: Why Remission Should Be the Goal
New clinical guidance on treatment-resistant depression urges full remission over symptom reduction, here's what it means for low-dose ketamine patients.
TRD Experts Push for Remission, Not Just Response
Psychiatrists are shifting TRD goals from symptom reduction to full remission. Here's what that means for ketamine patients and their treatment plans.
Beyond 'Less Bad': Rethinking Treatment-Resistant Depression
Clinicians are pushing beyond symptom reduction in treatment-resistant depression, aiming for full remission. Here's what that means for ketamine patients.
Low-Dose Ketamine for Complex Regional Pain Syndrome (CRPS)
How is low-dose ketamine used for complex regional pain syndrome? Review of infusion protocols, oral maintenance, and multimodal care strategies.
Low-Dose Ketamine for Eating Disorders: Anorexia, Bulimia, and Binge Eating
Learn what limited research says about low dose ketamine for anorexia, bulimia, and binge-eating disorder, plus safety and care coordination considerations.
Ketamine and the Gut-Brain Axis: How the Microbiome Influences Treatment Response
An in-depth look at the emerging research connecting ketamine therapy to the gut-brain axis, including how gut microbiome composition may predict and modulate ketamine's antidepressant and analgesic effects.
Ketamine and Liver Function Tests: Monitoring LFTs During Therapy
How and when to monitor liver function tests during low-dose ketamine therapy, including baseline panels, testing schedules, and abnormal LFT thresholds.
Ketamine and Immune Function: Immunomodulatory Effects of Low-Dose Ketamine
A research-focused review of ketamine's effects on the immune system, including its impact on innate and adaptive immunity, inflammatory cytokines, immune cell function, and implications for patients with autoimmune conditions and chronic inflammation.
Ketamine Therapy in Rural Communities: Overcoming Access Barriers
Learn how rural patients can assess ketamine therapy access, including telehealth, regional care models, safety planning, travel, and cost questions.
Low-Dose Ketamine for Phantom Limb Pain: Mechanisms, Evidence, and Treatment Approaches
Can low-dose ketamine help phantom limb pain? Review of NMDA-mediated central sensitization, infusion and oral protocols, and outcomes in amputee patients.